GRADUATORIA DEFINITIVA PROT. 2026/A22 PUNTEGGIO PROFESSIO AGGIUNTIVO NALI [p.60] /ISTRU ZIONE [p.40] Altra laurea, Attestati finali Attività di DOCENZA Tutor in Docente, Realizzazione di ECDL Competenze CAPACITA’ CONOSCEN Valutazio specifica laurea, abilitaz., in qualità di formatore in specifica consulente, Prodotti/P
Motivations for seeking treatment for ed: the woman's perspectiveMotivations for Seeking treatment for … From International Journal of Impotence Research Motivations for Seeking Treatment for ED: The
M P McCabe; H Conaglen; J Conaglen; E O'Connor
Posted: 03/29/2010; Int J Impot Res. 2010;22(2):152-158. 2010 Nature Publishing Group Abstract and Introduction
There is increasing evidence that partners have a major role in treatment-seeking behavior for men with ED. Thisstudy investigated the motivations of 100 females for seeking medical treatment for their partner's ED. Semi-structured interviews focused on reasons for seeking treatment from the female's perspective. The themes thatemerged from the data centered on the importance of sex in the relationship, with closeness and intimacyfrequently being seen as more important than sex. The second major theme related to hopes that females had inrelation to the medication, particularly in relation to increasing their partner's confidence and reducing his sexualfrustration. Enhancement of the relationship as well as improving the female's own feelings of self-doubt andsexual frustration were also mentioned. The results of this study show the multi-faceted nature of the motivationsthat females express in terms of seeking help for their partner's ED.
There is a growing body of literature that shows the importance of the partner and the relationship in the treatmentof ED in men.[1–7] Although a wide range of literature shows that PDE5 inhibitors (PDE5i) are very effective inrestoring an erection in men with ED, a large number of men do not continue with the use of these treatmentsfor their ED.[9–11] There are likely to be a wide range of factors that are associated with this discontinuation of PDE5i medication, orthe failure to even use these medications despite their efficacy.[11,12] One particular factor that has been identifiedis the importance of the views of the partner.[13–15] As sexual intercourse is a shared activity, it is not surprisingthat the views of the partner are likely to impact both on initial use and continuation or otherwise of medicaltreatment for ED.
A substantial number of studies have now shown that ED is associated with both quality of life and sexualdysfunction in the man's partner.[17–20] It is not clear from these studies if the ED led to female sexualdysfunction (FSD), if FSD led to male ED, or if there were other factors (for example relationship problems) thatled to both ED and FSD. However, there is evidence that treatment of male ED has a positive effect onFSD.[18,20–22] The use of a range of PDE5i medications has been shown to be associated with improvements inthe female partner's sexual function/satisfaction, as well as relationship functioning.
Cayan et al.  reported that all aspects of sexual functioning (except sexual desire) among 38 females whosepartners experienced ED were lower than for 49 partners of men who did not experience ED. Further, after thetreatment of ED, these females showed significant improvements in their sexual functioning. Chevret et al. also showed that ED had a negative impact on the sexuality of female partners. Female partners (n=376) of menwith ED evidenced lower levels of sexual satisfaction and sexual desire than female partners (n=345) of men whodid not have ED. Even life satisfaction was lower among the females whose partners experienced ED. Similarfindings were obtained by Heiman et al.  who found that postmenopausal females (n=85) whose partners weretreated for ED (compared with 91 females whose partners received a placebo) showed improvements in theirsexual function, sexual satisfaction, and treatment satisfaction. Finally, Fisher et al.  showed that thefrequency of orgasm, sexual activity, and sexual satisfaction was lower among females whose male partnersexperienced ED. Females whose partners were using PDE5i medications showed a more favorable sexualexperience than those females whose partners experienced ED, and were not using a PDE5i medication.
Motivations for Seeking treatment for … One would expect from the above studies that females whose partners experience ED would be keen to seektreatment for this condition. Consistent with this suggestion, Fisher et al.  found that there were high levels ofagreement between men and their partners on their perceptions of ED and their communication about ED. Incontrast, Mita et al.  found that among adult females recruited through the internet, almost half of themexpressed a negative attitude toward the use of drugs for ED. However, it is important to note that it is not knownif the partners of these females experienced ED, and all respondents were drawn from Japan. It is possible thatthe response to the use of PDE5i medication may be quite different once one's partner is diagnosed with ED, andbeyond that, prescribed and/or treated with PDE5i for the condition. Further, there may be different attitudes to theuse of medication to treat ED (or even any treatment of ED) within Japanese society compared with US society.
Given the central role that females have in their partners' treatment-seeking behavior,[26,7] it is important to obtaina better understanding of the reasons why females seek treatment. This study examined the motivation of femalesfor seeking treatment with PDE5i therapy for their partner's ED. The study used a qualitative approach to explorewomen's motivations. The results from this study are expected to provide data that will be useful in a large-scalequantitative study.
Materials and Methods
The data for this study were drawn from a sample of 100 females from New Zealand, whose partners wereexperiencing ED, determined by an Erectile Function subscale score ≤20, from the International Index of ErectileDysfunction. Participants were obtained through convenience sampling through advertisements for volunteersplaced in a local newspaper. Potential participants were informed that they would be taking part in a trial todetermine their satisfaction with two different PDE5 inhibitors. Participants ranged from 30 to 75 years of age, witha mean age of 53 years (s.d.=8.89), and the majority were Caucasian (83%). Eighty-two percent of the femaleswere married to their partners and had been in the present relationship from 3 months to 52 years, with a meanduration of 23 years (s.d.=14.95).
In depth, semi-structured interviews explored motivations for entering a treatment program for ED, such as thewoman's perspective on the importance of sex to the couple's relationship, as well as questions about hopes forbeginning the use of PDE5i medication, and any fears about their partners taking the medication. For example,females were asked, 'How important is obtaining treatment for your partner's ED, as far as you're concerned, toyou, and to your relationship?' Procedure
The study was approved by the regional ethics committee, and all participants provided informed consent to beinvolved in the study. The majority of females participated in face-to-face interviews, which were digitally recordedto enable repeated review during the analytical process. Interviews lasted ~20 min. Interviews were transcribedfrom the digital recordings, and then coded using NVivo software version 8. Coding and analysis were carriedout using principles from interpretative phenomenological analysis. Using this approach, transcripts wereexamined one by one, so that extracts could be grouped into relevant themes as they emerged. As the iterativeanalysis continued, themes were constantly revised and extended until no further themes could be identified, andthe resulting framework accounted for all relevant extracts found within the transcripts. A second coder, externalto the initial analysis, coded 10% of the interviews to ensure consistency of emerging themes. From the analysis,a number of main themes were identified.
Three major themes emerged in female's discussions of their motivation for their partner seeking ED medication.
These included the importance of sex to the relationship, hopes for the medication, and worries about themedication. These themes are considered in more detail below.
Motivations for Seeking treatment for … Importance of Sex
Table 1 outlines the main themes in relation to the importance of sex in the relationship. A common response wasthat sex was not the most important aspect of the relationship. Closeness and intimacy were often discussed asbeing more important than sex: Table 1. Frequencies for important of sex
'We do a lot of kissing and cuddling and stuff like that, I mean we are really close. We've been married for 35years and we can still sit on the sofa and hold hands. Because we have such a good relationship, I think it'swhat has enabled us to cope with this. I've been able to cope with it, and as long as I have my kisses andcuddles, I'm quite happy.' (#83, aged 54 years, duration of relationship 35 years) However, many females were also of the view that sex was part of a normal relationship: 'It's important, it's part of who you are as a couple. It's another way of expressing the love, the care, theenjoyment that you've got with that person.' (#89, aged 54 years, duration of relationship 15 years) Females were generally of the view that sex was more important to the male partner than the woman herself: 'I would probably say it's not wildly important to me—it's very important to my partner so it's important to mebecause it's important to him. I enjoy sex when we have it and sometimes I want to really participate andsometimes I don't—I'm not that bothered. I think at various times of the month—either side of my period—I'musually quite wanting sex and then for the rest of the month I couldn't give a toss but he certainly does.' (#31,aged 51 years, duration of relationship 15 years) A number of females indicated that they thought that sex increased their levels of intimacy and closeness withtheir partner: 'I feel, I like the intimacy, to me it's hand-in-hand with marriage, like, it makes me feel loved. I just really lovethe intimacy and the time, I mean, especially when you're so busy all the time, to me, that's our time out,together.' (#03, aged 45 years, duration of relationship 19 years) A number of females also noted that sex was not the most important aspect of their relationship because theybelieved that a decrease in sexual activity was a normal part of aging: 'I just put it down to getting older. I mean, I don't feel like sex as often as I used to and because we're busyand we're both getting older and I really just thought it was a part of aging and getting older. I mean, sexdrive, my understanding of it anyway, is that it should wane as you get older or maybe it doesn't, I don'tknow. My experience is that it does for us or for me and perhaps for my partner too.' (#32, aged 49 years,duration of relationship 30 years) Finally, some females saw sex as being a nice benefit to their relationship: 'I think, you know, I mean I'm not going to leave my partner because of it—because you know we've got adeeper situation than that. I mean that's not why we're together for the long term but I mean it is a nicebenefit to have on tops of it isn't it? So it is a nice plus.' (#35, aged 51 years, duration of relationship 29 Motivations for Seeking treatment for … Hopes for Medication
The main themes related to what the females hoped would occur as a result of using the PDE5i medication issummarized in Table 2. The themes from the female's responses centered on how the medication would help thefemales themselves, their partner, and their relationship. There were a number of themes surrounding hopes forthe medication that were focused on the impact of the woman herself. Examples of these three main themes ofhow the use of the PDE5i medication was expected to assist the females are outlined below.
Table 2. Frequencies of hopes for the medication
Reduce cognitive preoccupation, increase confidence Reduction in partner's sexual frustration Reduce hesitation about becoming involved in sex Reduce Own Feelings of Self-doubt
'It's impacted I would say quite a lot, we are at the stage now where we are able to talk about it, and we'remuch more open, I sort of think, it's me, I'm old, and you know, typical, he doesn't fancy me any more, I'm unattractive to him, and I went through all those self-doubt things, and that was impacting very badly. Wewere starting to grow apart, and as I say, we decided to talk about it, and open up, and he said look, it's gotto keep reinforcing that it's not me, it's just a thing that's happening, and we must work together.' (#53, aged52 years, duration of relationship 27 years) Reduction in Own Sexual Frustration
'It is very frustrating and I ended up saying 'we have to do something, because I'm 33 years old and I can't goon like this for the rest of my life'. And that was the trigger for him to say 'I'll go and do something'. He wasquite nervous I guess, and I can understand that it must be difficult for a guy to suddenly go in to the doctorand say 'I'm having problems'. Of course once the drug worked it was great and it seemed to restore someconfidence, but the other thing we found was that when he could have an erection he would ejaculate veryquickly, so it was all over within like 20 seconds. So again, that is very frustrating.' (#75, aged 33 years,duration of relationship 12 years) Reduce Hesitation about Becoming Involved in Sex
'It was a two way thing I think, I know personally it was just that attitude, oh look, don't even start. BecauseI'm not even going to try to be aroused, I got to the point where I wouldn't allow myself to get arousedbecause I thought, oh damn, I don't want to get like that, and then get so aroused, where you can't completethe job, and I'd just be left frustrated.' (#17, aged 49 years, duration of relationship 28 years) There were also three main themes surrounding hopes for how the medication would help the male partner.
Partner to Feel More Masculine
Motivations for Seeking treatment for … 'I feel deeply for my husband because he feels a failure as a man; if there was some form of treatment thatwould give him his erection function back again I would be only too happy; as much as anything just for hispeace of mind.' (#27, aged 65 years, duration of relationship 47 years) Reduce Cognitive Preoccupation, Increase Confidence
'But of course, what happens is, being a male, even though there's an underlying physical cause,psychologically it has a huge impact which probably compounds the whole situation even more. I thinkcertainly from (partner)'s perspective, if by using some medication then it's easier for him to become erect it'scertainly going to do his self-esteem and him a world of good, and hopefully he'll be feeling less sexuallyfrustrated, and that's got to have positive spin-offs in the rest of our relationship.' (#43, aged 46 years,duration of relationship 26 years) Reduction in Partner Sexual Frustration
he's happier, I'm happier. He just gets so frustrated with the whole thing when it doesn't work like he wants it to.' (#29, aged 54 years, duration of relationship 27 years) Finally, there were four themes that were focused more directly on the dyadic relationship and hopes for how themedication might help the couple.
Increase Intimacy and Closeness
'Of course, the desire and the arousal depend so much on the situation, and a lot of different things comeinto it. And I can, in the past, I can remember being so aroused, and so full of wanting to get going, but whenyou kind of get into a relationship, and you've been together for quite a long time, things change. So I don'tfeel a lot of desire now, but what I'm wanting is the closeness, and I'm wanting it for (partner), so that he can,you know, experience that again.' (#14, aged 66 years, duration of relationship 18 years) Return to Normal Life
'Strangely we're still getting on fine and we thought 'well this is how it will be till the end of our days', but itwould be nice if it could be like it was.' (#79, aged 66 years, duration of relationship 48 years) Determine How the Medication Works
'To find a product, obviously, because we're going to have to use a product, we know that now. To find aproduct that's going to suit both of us and for the side effects not to be too damaging.' (#92, aged 49 years,duration of relationship 25 years) Enhance the Relationship
'I think that probably, if the sex in the relationship was right, everything else would balance out.' (#90, aged35 years, duration of relationship 6 years) Table 3 summarizes the frequencies of the main worries that the females expressed in relation to their partner'suse of the PDE5i medication. There were five major themes that arose regarding these worries.
Table 3. Frequencies of worries for the medication
Motivations for Seeking treatment for … Side Effects and Health Issues
'Oh only what you hear, you know, I'd hate him to drop dead of a heart attack or anything! But he's beenfairly extensively tested for his health and he's a real physical health nut person so I don't imagine he putshimself under any more stress than when he's working out at the gym or walking up mountains or things likethat.' (#31, aged 51 years, duration of relationship 15 years) Cost of Medication
'I was going to say to you, we're not that financial and it's just horrendous, the cost, you know, one hundreddollars for four tablets, that's, you know, there's times that we just can't get them, and we can go on forweeks or months and then I get really frustrated too, and I know (husband) does too. Because, you know,we've got a family, and we've got bills to pay, so it's like, but then I think to myself, gosh, this is part of ourlife now, and you know, we need something for us as well, and I think sometimes that, I think it is importantthat we put money aside to try and get them, but it's not always possible.' (#03, aged 41 years, duration ofrelationship 19 years) Not Natural
'It doesn't light my fire, but if it's going to help (partner) then that's fine with me. Because you know we had alittle sample tablet and we had one and it was just, we couldn't get over how it works. To me, I feel it's a bitout of nature, but, one minute you can't do it and the next minute suddenly wow! And you can do it about1000 darn times, you know? And to me that's just not a natural process. But if it's going to give (partner)some satisfaction well that's fine with me.' (#19, aged 50 years, duration of relationship 31 years) Puts Pressure on Woman to Perform
'I think, if you have a pretty full-on day, really all you want is a cup of tea. 'Oh, I've taken a pill'; well, it doesn'talways work that way I don't think. Because, I think it's going to be easier for him, having the pill, to be intoit, than for me who doesn't have a pill. I mean, he's going to be able to perform, whereas a woman can'talways perform at that time.' (#16, aged 55 years, duration of relationship 33 years) That it will Take Away the Spontaneity
'But I find with me, if he tells me he's taken a tablet, then I don't want it. You know, I don't want sex.
Because to me sex is something you do just out of the blue, you know? That's where the excitement and allthat comes into it. And when you think oh hell, I've got to do that.' (#91, aged 48 years, duration ofrelationship 28 years) Discussion
This analysis of female's motivation for treatment revealed that a large number of the themes related to theirpartner's sexual and psychological functioning. Female partners wanted the partner to feel better about himself(more confident and masculine), and through addressing his needs, they expected that there would be a flow-oneffect to their own sexual and interpersonal relationship. Many of the females indicated that sexual performancewas more important to their partner than to them. In fact, they were of the view that closeness and intimacy wasmore important to them than sexual interactions. Interestingly, many females viewed sex as being part of anormal relationship, and a number of them experienced sexual frustration if they could not have sex with theirpartner. As suggested by Chevret-Méasson et al., females' satisfaction with their sex lives were improved withthe use of PDE5i medication and this is a central motive for females to seek treatment for their partner's ED.
Females expressed a number of concerns about using medication for their partner's ED. These primarily focusedon the cost of the medication, the side effects, pressure on them to perform as well as the lack of spontaneitythat may result from the use of the medication.
These results are useful for identifying what motivates females seeking treatment for their male partner's ED.
Earlier research has shown that treatment of male ED has a positive impact on FSD, as well as on their levels ofsexual satisfaction.[18,13,22,23] This study shows that the main motives for females seeking treatment for theirpartner's ED primarily center on their partner's needs rather than their own level of s.d. The other major motive was Motivations for Seeking treatment for … to improve the level of intimacy and communication in their relationship. These results would suggest that thefemales in the study were supportive of their partner seeking help for his ED, and were likely to have a role in histreatment-seeking behavior.
The themes emerging from the data also centered on the male's sense of masculinity and confidence. Rosen etal.  found that treatment of ED using PDE5i medication led to an improvement in the quality of life of treatedmales, and that this relationship was mediated by mood and their relationship with their partner. Overall, theseresults show the broader impact of treatment on the lives of males with ED, and that female partners are aware ofthese change. Further, females seek treatment for their partner's ED in an attempt to achieve positive changes intheir partner's lives, as well as broader aspects of their own life.
It is important to note that the couples in this study may not be representative of the general population, in thatthey were all motivated to be in the study, and hence, to seek treatment. Also many of them had been in theircurrent relationship for a long period of time. Future studies need to further explore the role that female partnershave in men with ED seeking treatment for this condition. Given that so many men do not continue with PDE5imedication despite its effectiveness in treating their ED, it is important to understand the role that their partnerhas in initiating and continuing this treatment regime. In this way, treating physicians will have the information toenlist the assistance of partners to ensure that men seek and continue treatment for ED. Such a process is likelyto improve both male and female s.d., enhance their quality of life, and improve the level of intimacy andcommunication in their relationship.
1. Althof SE, Eid JF, Talley DR, Brock GB, Dunn ME, Tomlin ME et al. Through the eyes of females: the partners' perspective on tadalafil. Urol 2006; 68: 631–635.
2. Fisher WA, Eardley I, McCabe MP, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples 1: couple conceptions of ED. J Sex Med 2009; 6: 2746–2760.
3. Hackett G, Kell P, Ralph D, Dean J, Price D, Speakman M et al. British Society for Sexual Medicine guidelines on the management of erectile dysfunction. J Sex Med 2008; 5: 1841–1865.
4. McCabe MP, Matic H. Erectile dysfunction and relationships: views of men with erectile dysfunction and their partners. Sex Rel Ther 2008; 1: 51–60.
5. Ralph D, Eardley I, Kell P, Dean J, Hackett G, Collins O et al. Improvement in erectile function on vardenal treatment correlates with treatment satisfaction in both patients and their partners. BJU Int 2007; 100: 357–361.
6. Riley A. The role of the partner in erectile dysfunction and its treatment. Int J Impot Res 2002; 14: S105– 7. Shabsigh R, Perelman MA, Laumann EO, Lockhart DC. Drivers and barriers to seeking treatment for erectile dysfunction: a comparison of six countries. BJU Int 2004; 94: 1055–1065.
8. Brock G. Oral agents: first-line therapy for erectile dysfunction. Euro Urol 2002; S1: 12–18.
9. Klotz T, Mathers M, Klotz R, Sommer F. Why do patients with erectile dysfunction abandon effective therapy with sildenafil (Viagra)? Int J Impot Res 2005; 17: 2–4.
10. Sato Y, Tanda H, Kato S, Onishi S, Nitta T, Koroku M. How long do patients with erectile dysfunction continue to use sildenal citrate? Dropout rate from treatment course as outcome in real life. Int J Urol 2007;14: 339–342.
11. Souverein PC, Egberts ACG, Meuleman EJH, Urquhart J, Leufkens HGM. Incidence and determinants of sildenal (dis)continuation: the Dutch cohort of sildenal users. Int J Impot Res 2002; 14: 259–265.
12. Ströberg P, Hedelin H, Bergström A. Is sex only for the healthy and wealthy? J Sex Med 2007; 4: 176– 13. Conaglen HM, Conaglen JV. Investigating females's preference for sildenal or tadalal use by their partners with erectile dysfunction: the partners' preference study. J Sex Med 2008a; 5: 1198–1207.
14. Fisher WA, Rosen C, Eardley I, Sand M, Goldstein I. Sexual experience of female partners of men with erectile dysfunction: the female experience of men's attitudes to life events and sexuality (FEMALES)study. J Sex Med 2005; 2: 675–684.
15. Fisher WA, Eardley I, McCabe MP, Sand M. Erectile dysfunction (ED) is a shared sexual concern of couples 11: associations of female partner characteristics with male partner Ed treatment seeking an Motivations for Seeking treatment for … phosphodiesterase type 5 inhibitor utilization. J Sex Med 2009; 6: 3111–3124.
16. Wagner G, Fugl-Meyer KS, Fugl-Meyer AR. Impact of erectile dysfunction on quality of life: patient and partner perspectives. Int J Impot Res 2000; 12: pS144, 1p.
17. Cameron A, Tomlin M. The effect of male erectile dysfunction on the psychosocial, relationship and sexual characteristics of heterosexual females in the United States. J Sex Marital Ther 2007; 33: 135–149.
18. Cayan S, Bozlu M, Canpolat B, Akbay E. The assessment of sexual functions in females and male partners complaining of erectile dysfunction: does treatment of male sexual dysfunction improve femalepartner's sexual functions? J Sex Marital Ther 2004; 30: 333–341.
19. Chevret M, Jaudinot E, Sullivan K, Marrel A, De Gendre AS. Impact of erectile dysfunction (ED) on sexual life of female partners: assessment with the Index of Sexual Life (ISL) Questionnaire. J Sex Marital Ther2004; 30: 157–172.
20. Rosen R, Janssen E, Wiegel M, Bancroft J, Althof S, Wincze J et al. Psychological and interpersonal correlates in men with erectile dysfunction and their partners: a pilot study of treatment outcome withSildenafil. J Sex Marital Ther 2006; 32: 215–234.
21. Conaglen HM, Conaglen JV. The impact of erectile dysfunction on female partners: a qualitative investigation. Sex Rel Ther 2008b; 23: 147–156.
22. Fisher WA, Rosen R, Mollen M, Brock G, Karlin G, Pommerville P et al. Improving the sexual quality of life of couples affected by erectile dysfunction: a double-blind, randomized, placebo-controlled trial ofvardenafil. J Sex Med 2005; 2: 699–708.
23. Heiman JR, Talley DR, Bailen JL, Oskin TA, Rosenberg SJ, Pace CR et al. Sexual function and satisfaction in heterosexual couples when men are administered sildenafil citrate (Viagra) for erectiledysfunction: a multicentre, randomised, double-blind, placebo-controlled trial. Bri J Obstet Gynaecol 2007;114: 437–447.
24. Fisher WA, Meryn S, Sand M. Communication about erectile dysfunction among men with ED, partners of men with ED, and physicians: the strike up a conversation study (Part 11). J Men's Health Gender 2005; 2:309–317.
25. Mita K, Shingeta M, Kakehashi M, Matsubara A, Teishima J, Kato M et al. Females's perception of male erectile dysfunction drugs in the general population. Maturitas 2007; 56: 216–222.
26. Moreira EDJ, Brock GB, Glasser DB, Nicolosi A, Laumann EO, Paik A et al. Help-seeking behaviour for sexual problems: the Global Study of Sexual Attitudes and Behaviors. Int J Clin Pract 2005; 59: 6–16.
27. Rosen RC, Riley A, Wagner G, Osterloh IH, Kirkpatrick J, Mishra A. The international index of erectile function (IIEF): a multidimensional scale for assessment of erectile dysfunction. Urol 1997; 49: 822–830.
28. NVivo qualitative data analysis software. QRS International Pty Ltd. Version 8, 2008.
29. Smith JA, Osborn M. Interpretative phenomenological analysis. In: JA Smith (ed). Qualitative Psychology: A Practical Guide to Research Methods. SAGE Publications: London, 2003.
30. Chevret-Méasson M, Lavalée E, Troy S, Arnould B, Oudin S, Cuzin B. Improvement in quality of sexual life in female partners of men with erectile dysfunction treated with Sildenafil Citrate: findings of the Index ofSexual Life (ISL) in Couple Study. J Sex Med 2009; 6: 761–769.
31. Rosen RC, Seidman SN, Menza MA, Shabsigh R, Roose SP, Tseng LJ et al. Quality of life, mood, and sexual function: a path analytic model of treatment effects in men with erectile dysfunction and depressivesymptoms. Int J Impot Res 2004; 16: 334–340.
Authors and Disclosures
M P McCabe1, H Conaglen2, J Conaglen3 and E O'Connor1
1School of Psychology Deakin University, Melbourne, VIC, Australia; 2Psychology Department, University ofWaikato, Hamilton, New Zealand and 3Waikato Clinical School, University of Auckland, Hamilton, New Zealand Correspondence
Professor MP McCabe, School of Psychology, Deakin University, 221 Burwood Highway, Burwood, VIC 3125
Australia. E-mail: email@example.com
Conflict of interest
Motivations for Seeking treatment for … The authors declare no conflict of interest.
Int J Impot Res. 2010;22(2):152-158. 2010 Nature Publishing Group
SUCRALFATE TABLETS, USP DESCRIPTION Sucralfate is an ␣-D-glucopy- ranoside, ␤-D-fructofuranosyl-, octakis-(hydrogen sulfate), alu- minum complex. Tablets for oral administrationcontain 1 g of sucralfate, USP. nesium stearate, and colloidalsilicon dioxide. CLINICAL PHARMACOLOGY Sucralfate is only minimally absorbed from the gastrointestinal tract. The small amounts of the sulfated